LAMP3 and adenocarcinoma in situ: LAMP3 has previously been detected in OPA but is rarely expressed in human tumors, except in bronchioloalveolar adenocarcinoma (lepidic-prominent adenocarcinoma in situ) (62), which was not represented in the LUAD cases in the TGCA data studied.